$85.97 +0.18 (%) Ligand Pharmaceuticals Inc - NASDAQ

Feb. 12, 2016 | 04:00 PM

Partner Headlines

  1. Stocks Fight Off Early Losses; Universal Display, Masco Soar

    IBD | Feb. 9, 2016 | 10:51AM EST
  2. Biotech ETFs Rally As Oil Bubbles Up 8%; Gold Hits 3-Month High

    IBD | Feb. 3, 2016 | 13:05PM EST
  3. 5 Top Stocks Getting Ready For Next Market Rally

    IBD | Jan. 22, 2016 | 18:06PM EST
  4. Ligand Has Highest Debt To Equity Among Biotechs

    IBD | Jan. 22, 2016 | 18:06PM EST
  5. Stocks Higher, But American Express Holds Back Dow

    IBD | Jan. 22, 2016 | 13:31PM EST
  6. Stocks Rumble Higher At Open; LinkedIn, United, Skyworks Jump

    IBD | Jan. 22, 2016 | 10:43AM EST
  7. Stocks Pare Losses As Techs Reverse, But IBM Still Depressed

    IBD | Jan. 20, 2016 | 15:21PM EST
  8. Stock Rout Deepens As Oil Sinks Below $27; Netflix Loses Support

    IBD | Jan. 20, 2016 | 13:33PM EST
  9. Stock Gains Diminish; Amazon, Facebook, Alphabet Get Upgrade

    IBD | Jan. 12, 2016 | 11:55AM EST
  10. RS Investment Increases Holdings in Ulta Salon, Noble Energy and Fortune Brands

    GuruFocus | Dec. 23, 2015 | 11:19AM EST
  11. LIGAND PHARMACEUTICALS

    IBD | Dec. 17, 2015 | 19:25PM EST
  12. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  13. Stocks Trend Lower; Solar Energy Stocks Socked On Poor Earnings

    IBD | Nov. 10, 2015 | 11:48AM EST
  14. Spectrum Pharmaceuticals Receives CRL from FDA for EVOMELA for Injection

    Benzinga | Oct. 23, 2015 | 04:22AM EST
  15. Dan Loeb's Latest Activist Target Baxter International

    GuruFocus | Aug. 6, 2015 | 18:41PM EST
  16. These Two Biotechs Boast Big EPS Growth Rates

    IBD | Aug. 6, 2015 | 11:14AM EST
  17. LIGAND PHARMACEUTICALS

    IBD | Jun. 2, 2015 | 18:36PM EST
  18. Regeneron, Lannett Among The 4 Top-Rated Drug Stocks

    IBD | May. 28, 2015 | 08:02AM EST
  19. Actavis, Ligand Top Q1 Views

    IBD | May. 11, 2015 | 18:46PM EST
  20. Actavis Offers Post-Allergan Guidance; Ligand Jumps

    IBD | May. 11, 2015 | 18:36PM EST
  21. Q1 Earnings Drive Industry Group Winners And Losers

    IBD | May. 8, 2015 | 18:59PM EST
  22. CRT Capital Initiates Ligand Pharmaceuticals With Buy

    Benzinga | Mar. 3, 2015 | 09:24AM EST
  23. Benzinga's Top Initiations

    Benzinga | Mar. 3, 2015 | 09:07AM EST
  24. Morning Market Losers

    Benzinga | Feb. 9, 2015 | 10:00AM EST
  25. UPDATE: Ligand Pharmaceuticals Posts In-Line Q4 Earnings, Issues Weak Outlook

    Benzinga | Feb. 9, 2015 | 09:17AM EST
  26. Earnings Scheduled For February 9, 2015

    Benzinga | Feb. 9, 2015 | 04:58AM EST
  27. UPDATE: Deutsche Bank Initiates Coverage On Ligand Pharmaceuticals On Growing Royalty Play On Biopharma

    Benzinga | Dec. 2, 2014 | 08:05AM EST
  28. Lemelson Capital Management CIO Discusses Ligand Pharmaceuticals Prior To Company Issuing Weak Guidance

    Benzinga | Nov. 18, 2014 | 15:56PM EST
  29. Why Lemelson Capital Is Short On Ligand Pharmaceuticals

    Benzinga | Oct. 17, 2014 | 15:52PM EST
  30. Dow Surges Over 200 Points After FOMC Minutes; Blackhawk Shares Jump On Strong Results

    Benzinga | Oct. 8, 2014 | 15:40PM EST
  31. Interface Drops On Q3 Warning; Symantec Shares Rise

    Benzinga | Oct. 8, 2014 | 14:03PM EST
  32. Ligand Pharmaceuticals Inc. Shares Gain On Q3 Pre-Announcement

    Benzinga | Oct. 8, 2014 | 11:35AM EST
  33. Mid-Morning Market Update: Markets Mostly Flat; Costco Posts Upbeat Earnings

    Benzinga | Oct. 8, 2014 | 10:00AM EST
  34. Morning Market Movers

    Benzinga | Oct. 8, 2014 | 09:36AM EST
  35. Stocks To Watch For August 12, 2014

    Benzinga | Aug. 12, 2014 | 04:04AM EST
  36. Exclusive: Emmanuel Lemelson Talks Ligand Pharmaceuticals

    Benzinga | Aug. 7, 2014 | 13:57PM EST
  37. Ligand Pharmaceuticals Reports Earnings; Lemelson Capital Adds To Short Position

    Benzinga | Aug. 4, 2014 | 15:45PM EST
  38. Earnings Scheduled For August 4, 2014

    Benzinga | Aug. 4, 2014 | 05:14AM EST
  39. Fed Says Districts Were Optimistic On Economic Outlook; Yahoo! Falls On Downbeat Results

    Benzinga | Jul. 16, 2014 | 15:57PM EST
  40. Yahoo Falls On Downbeat Results; Time Warner Shares Spike Higher

    Benzinga | Jul. 16, 2014 | 13:36PM EST
  41. Benzinga's Volume Movers

    Benzinga | Jun. 24, 2014 | 10:41AM EST
  42. Ligand to Present Positive Data from Phase 1 Study of Effect of SERN Lasofoxifene

    Benzinga | Jun. 23, 2014 | 08:03AM EST
  43. Shares Of Ligand Follow Parabolic Curve Amid Responses Surrounding Promacta's Phase III Trial

    Benzinga | Jun. 17, 2014 | 12:26PM EST
  44. Ligand Pharmaceuticals - Severe competitive threat to key royalty program and "going ...

    GuruFocus | Jun. 16, 2014 | 18:37PM EST
  45. Indexes End With Small Gains; Tesla Drives Higher

    IBD | Jun. 16, 2014 | 16:25PM EST
  46. UPDATE: Ligand Signs Research and Licensing Agreement with Omthera Pharmaceuticals for Dyslipidemia-related Diseases

    Benzinga | May. 14, 2014 | 08:35AM EST
  47. UPDATE: Ligand Pharma Announces Milestone from Sage Therapeutics for SAGE-547

    Benzinga | May. 12, 2014 | 08:05AM EST
  48. Spectrum Pharmaceuticals' Pivotal Trial of Captisol-Enabled (Propylene Glycol-Free) Melphalan Meets Primary Endpoint

    Benzinga | Apr. 23, 2014 | 07:12AM EST
  49. UPDATE: MLV & Co Reiterates on Ligand Pharmaceuticals Following Strong 4Q Report

    Benzinga | Feb. 13, 2014 | 08:08AM EST
  50. Stocks End Near Session Highs; Ligand, Regeneron Jump

    IBD | Feb. 11, 2014 | 16:24PM EST
Trading Center